Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

OTHER(1)
This study is observational. Only patients who have previously tested positive for SARS-CoV-2 infection or are experiencing ongoing symptoms.
1 trial
university-of-north-carolina-chapel-hill
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07781501Recruiting
Long-Term Study of COVID-19 Infection and Long COVID
SARS CoV-2 Post-Acute Sequelae
PrincipalinvestigatorStart date: 2024-09-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

SARS CoV-2 Post-Acute Sequelae1

Affiliations

University of North Carolina, Chapel Hill

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

1 similar investigators found

Jonathan McConathy, MD, PhD

University of Alabama at Birmingham

Moderately Similar
6 trials

Shared therapeutic areas:

SARS CoV-2 Post-Acute Sequelae
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07781501PrincipalInvestigator

Long-Term Study of COVID-19 Infection and Long COVID

SARS CoV-2 Post-Acute Sequelae
Recruiting

All 1 trials loaded